412 related articles for article (PubMed ID: 21785258)
1. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".
Miki K
Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(7):405-14. PubMed ID: 21785258
[TBL] [Abstract][Full Text] [Related]
2. Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels--The ABC Method.
Yamaguchi Y; Nagata Y; Hiratsuka R; Kawase Y; Tominaga T; Takeuchi S; Sakagami S; Ishida S
Digestion; 2016; 93(1):13-8. PubMed ID: 26789514
[TBL] [Abstract][Full Text] [Related]
3. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
4. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
5. Analysis of ABC (D) stratification for screening patients with gastric cancer.
Kudo T; Kakizaki S; Sohara N; Onozato Y; Okamura S; Inui Y; Mori M
World J Gastroenterol; 2011 Nov; 17(43):4793-8. PubMed ID: 22147980
[TBL] [Abstract][Full Text] [Related]
6. Usefulness and Limitations of a Serum Screening System to Predict the Risk of Gastric Cancer.
Kishino T; Oyama T; Tomori A; Takahashi A; Shinohara T
Intern Med; 2020 Jun; 59(12):1473-1480. PubMed ID: 32188803
[TBL] [Abstract][Full Text] [Related]
7. Identification of Helicobacter pylori-related gastric cancer risk using serological gastritis markers and endoscopic findings: a large-scale retrospective cohort study.
Nagasaki N; Ito M; Boda T; Kotachi T; Takigawa H; Oka S; Tanaka S
BMC Gastroenterol; 2022 Jun; 22(1):299. PubMed ID: 35725370
[TBL] [Abstract][Full Text] [Related]
8. Combining the serum pepsinogen level and Helicobacter pylori antibody test for predicting the histology of gastric neoplasm.
Choi HS; Lee SY; Kim JH; Sung IK; Park HS; Shim CS; Jin CJ
J Dig Dis; 2014 Jun; 15(6):293-8. PubMed ID: 24602176
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of two serological methods in screening gastric cancer and its precancerous condition].
Li MY; Zhang DQ; Lu X; Chen WC
Zhonghua Nei Ke Za Zhi; 2018 Dec; 57(12):907-911. PubMed ID: 30486559
[No Abstract] [Full Text] [Related]
10. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
[TBL] [Abstract][Full Text] [Related]
11. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
12. Development of gastric cancer in nonatrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis.
Watanabe M; Kato J; Inoue I; Yoshimura N; Yoshida T; Mukoubayashi C; Deguchi H; Enomoto S; Ueda K; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Tekeshita T; Mohara O; Ushijima T; Ichinose M
Int J Cancer; 2012 Dec; 131(11):2632-42. PubMed ID: 22383377
[TBL] [Abstract][Full Text] [Related]
13. Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.
Kotachi T; Ito M; Yoshihara M; Boda T; Kiso M; Masuda K; Matsuo T; Tanaka S; Chayama K
Digestion; 2017; 95(4):314-318. PubMed ID: 28571035
[TBL] [Abstract][Full Text] [Related]
14. The new modified ABCD method for gastric neoplasm screening.
Park CH; Kim EH; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
Gastric Cancer; 2016 Jan; 19(1):128-35. PubMed ID: 25663259
[TBL] [Abstract][Full Text] [Related]
15. Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome.
Takeoka A; Tayama J; Yamasaki H; Kobayashi M; Ogawa S; Saigo T; Hayashida M; Shirabe S
PLoS One; 2016; 11(11):e0166588. PubMed ID: 27851820
[TBL] [Abstract][Full Text] [Related]
16. High-Negative Anti-
Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
[TBL] [Abstract][Full Text] [Related]
17. Serum pepsinogens, gastrin-17 and Helicobacter pylori antibody in the residents of two cities in china with distinct mortality rates of gastric cancer.
Zheng KC; Aoki K; Li XQ; Lin SG; Wu BS; Zhong WL; Chen TH; Lin S; You JW; Su C
Tohoku J Exp Med; 2012 Dec; 228(4):289-94. PubMed ID: 23117263
[TBL] [Abstract][Full Text] [Related]
18. Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
Hamashima C; Sasazuki S; Inoue M; Tsugane S;
BMC Cancer; 2017 Mar; 17(1):183. PubMed ID: 28279154
[TBL] [Abstract][Full Text] [Related]
19. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection.
Di Mario F; Moussa AM; Caruana P; Merli R; Cavallaro LG; Cavestro GM; Dal Bò N; Iori V; Pilotto A; Leandro G; Franzè A; Rugge M
Scand J Gastroenterol; 2003 Dec; 38(12):1223-7. PubMed ID: 14750641
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
